back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-25 15:18 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-25 14:58 Tx date 2024-06-06 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-25 08:58 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,900
+29,800 vol $0.50 each |
29,800 | |
| Filed 2026-03-25 08:57 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$29,762
+59,525 vol $0.50 each |
59,525 | |
| Filed 2026-03-25 08:55 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,032
+59,600 vol $0.42 each |
59,600 | |
| Filed 2026-03-25 08:51 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,001
+119,050 vol $0.42 each |
369,050 | |
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
||
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:56 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$44,662
+89,325 vol $0.50 each |
||
| Filed 2025-11-14 14:53 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,033
+178,650 vol $0.42 each |
||
| Filed 2024-06-11 10:18 Tx date 2024-06-06 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-02 18:19 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+13,587 vol $0.46 each |
87,327 | |
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
29,762 | |
| Filed 2025-11-14 15:01 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
59,524 | |
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|